IT1394302B1 - "NEW HYBRID PARTICLES AND THEIR USE IN DIAGNOSIS AND THERAPY" - Google Patents
"NEW HYBRID PARTICLES AND THEIR USE IN DIAGNOSIS AND THERAPY"Info
- Publication number
- IT1394302B1 IT1394302B1 ITMI2009A000887A ITMI20090887A IT1394302B1 IT 1394302 B1 IT1394302 B1 IT 1394302B1 IT MI2009A000887 A ITMI2009A000887 A IT MI2009A000887A IT MI20090887 A ITMI20090887 A IT MI20090887A IT 1394302 B1 IT1394302 B1 IT 1394302B1
- Authority
- IT
- Italy
- Prior art keywords
- diagnosis
- therapy
- hybrid particles
- new hybrid
- new
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0026—Acridine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0089—Particulate, powder, adsorbate, bead, sphere
- A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
- A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000887A IT1394302B1 (en) | 2009-05-20 | 2009-05-20 | "NEW HYBRID PARTICLES AND THEIR USE IN DIAGNOSIS AND THERAPY" |
PCT/IB2010/001145 WO2010133941A2 (en) | 2009-05-20 | 2010-05-17 | New hybrid particles and their use in diagnostics and therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000887A IT1394302B1 (en) | 2009-05-20 | 2009-05-20 | "NEW HYBRID PARTICLES AND THEIR USE IN DIAGNOSIS AND THERAPY" |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20090887A1 ITMI20090887A1 (en) | 2010-11-21 |
IT1394302B1 true IT1394302B1 (en) | 2012-06-06 |
Family
ID=41506422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2009A000887A IT1394302B1 (en) | 2009-05-20 | 2009-05-20 | "NEW HYBRID PARTICLES AND THEIR USE IN DIAGNOSIS AND THERAPY" |
Country Status (2)
Country | Link |
---|---|
IT (1) | IT1394302B1 (en) |
WO (1) | WO2010133941A2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071535B2 (en) * | 2003-09-12 | 2011-12-06 | The Regents Of The University Of California | Guanidinium derivatives for improved cellular transport |
WO2006102307A2 (en) * | 2005-03-21 | 2006-09-28 | University Of Louisville Research Foundation, Inc. | Target specific nanoparticles for enhancing optical contrast enhancement and inducing target-specific hyperthermia |
WO2008140624A2 (en) * | 2006-12-22 | 2008-11-20 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to hybird nanoparticles |
US8361437B2 (en) * | 2007-08-28 | 2013-01-29 | University Of Florida Research Foundation, Inc. | Multimodal nanoparticles for non-invasive bio-imaging |
-
2009
- 2009-05-20 IT ITMI2009A000887A patent/IT1394302B1/en active
-
2010
- 2010-05-17 WO PCT/IB2010/001145 patent/WO2010133941A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010133941A2 (en) | 2010-11-25 |
ITMI20090887A1 (en) | 2010-11-21 |
WO2010133941A3 (en) | 2011-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258817A1 (en) | Synthetic triterpenoids and methods of use in the treatment of disease | |
SMT201500206B (en) | Spiro-oxindolic compounds and their use as therapeutic agents | |
SMT201400146B (en) | Morpholino pyrimidine and their use in therapy | |
PT3042910T (en) | 2'-spiro-nucleosides for use in the therapy of hepatitis c | |
SMT201400164B (en) | Morpholino pyrimidine and their use in therapy | |
HK1171458A1 (en) | Antibodies against human il 17 and uses thereof il17 | |
IT1391530B1 (en) | ACTIVE PARTICLES FOR BIO-ANALYTICAL APPLICATIONS AND METHODS FOR THEIR PREPARATION | |
HK1146596A1 (en) | Use of lingo-4 antagonists in the treatment of conditions involving demyelination lingo-4 | |
IL222605A (en) | Apparatus and kit for encapsulating at least one compound in erythrocytes for therapeutic and/or diagnostic use | |
GB0708585D0 (en) | Novel antibody and use in diagnosis and therapy of arthropathies | |
IL214244A0 (en) | Scriptaid isosteres and their use in therapy | |
IT1398268B1 (en) | GLYCEROSOMES AND THEIR USE IN PHARMACEUTICAL AND COSMETIC PREPARATIONS FOR TOPICAL USE | |
BR112013008704A2 (en) | "waste pick-up coil dispenser and methods of use" | |
IT1401531B1 (en) | SYSTEM CAN BE USED IN TWO MODES | |
IL212672A (en) | Cycloundecadepsipeptide compounds and use of said compounds in the manufacture of medicaments | |
ZA201300183B (en) | " backing having three -layer structure and aqueous patch using the backing " | |
GB0920258D0 (en) | New medical agents and use thereof | |
FI20106220A0 (en) | Procedure and arrangement in connection with wheelchair operation | |
EP2449126A4 (en) | Novel antibodies and their uses in therapeutic and diagnostic methods | |
BRPI0923886A2 (en) | "use of ammonium chloride in therapy" | |
PT2670769T (en) | R2r1/2 in diagnosis and therapy | |
BRPI1012325A2 (en) | use of microrna-199b-5p in the medical and diagnostic field. " | |
HK1182397A1 (en) | New octapeptide compounds and their use in therapy | |
IT1394302B1 (en) | "NEW HYBRID PARTICLES AND THEIR USE IN DIAGNOSIS AND THERAPY" | |
BR112013010061A2 (en) | "pharmaceutical composition, composition and use" |